The peripheral blood eosinophil count is considered to be one of the most reliable, straightforward and methodologically simple biomarkers for classifying asthma subtypes, with serial blood measurements routinely used for monitoring the response to anti-IL-5 therapies [29]. This evidence concerns the gene IL5 and asthma.